Status:
TERMINATED
Study Evaluating the Safety and Efficacy of Proellex® in the Treatment of Endometriosis-extension Study
Lead Sponsor:
Repros Therapeutics Inc.
Conditions:
Endometriosis
Eligibility:
FEMALE
18-48 years
Phase:
PHASE2
Brief Summary
ZPE-201 Extension of treatment
Detailed Description
This is an extension of the phase II, three-arm, parallel design, dose-ranging, placebo-controlled, randomized, double-blind, multicenter study in which placebo or one (1) of two (2) dose levels of Pr...
Eligibility Criteria
Inclusion
- Only subjects treated in the ZPE-201 study will be allowed to enter the extension study.
- Subjects who withdrew from ZPE-201 due to lack of treatment efficacy will also be invited to participate.
Exclusion
- All other subjects
Key Trial Info
Start Date :
February 28 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2009
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00958412
Start Date
February 28 2009
End Date
August 31 2009
Last Update
February 12 2019
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Advanced Clinical Therapeutics, LLC
Tucson, Arizona, United States, 85712
2
Medical Center for Clinical Research
San Diego, California, United States, 92108
3
Compass Clinical Research
San Ramon, California, United States, 94583
4
Comprehensive Clinical Trials
West Palm Beach, Florida, United States, 33409